Gaithersburg, Maryland, United States Leadiant Biosciences is the famous Corporate Investor, which was founded in 1980. The company was established in North America in United States. The main office of represented Corporate Investor is situated in the Gaithersburg.
The usual cause for the fund is to invest in rounds with 9 partakers. The meaningful sponsors for the fund in investment in the same round are Rosalind Capital Partners, Rockmore Capital, OpusPoint Partners. In the next rounds fund is usually obtained by Third Security.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. We can highlight the next thriving fund investment areas, such as Biopharma, Biotechnology. Among the most popular portfolio startups of the fund, we may highlight Soligenix.
The increased amount of exits for fund were in 2016. The top activity for fund was in 2010. The fund is constantly included in less than 2 deals per year. The usual things for fund are deals in the range of 5 - 10 millions dollars.
Related Funds
| Fund Name | Location |
| Audencia | France, Nantes, Pays de la Loire |
| Bingshen Investment | China, Guangdong, Shenzhen |
| China Merchants Innovation Investment Management | - |
| D.T. Lake Equity Investment | China, Jingan, Shanghai |
| Dauphin Capital Partners | New York, New York, United States |
| East Midlands Business Angels | Newark Upon Trent, Nottinghamshire, United Kingdom |
| Euronext | Amsterdam, Noord-Holland, The Netherlands |
| General Technology Venture Capital | Beijing, Beijing, China |
| Global Health Investment Fund (GHIF) | New York, New York, United States |
| Guardian Media Group | England, London, United Kingdom |
| Hoop Partners | - |
| Hypersphere Ventures | - |
| Mark VC | Bellaire, Texas, United States |
| Petunia Estate | - |
| Redbrick | British Columbia, Canada, Victoria |
| Spartech Ventures | Dubai, United Arab Emirates |
| Two Point O Fund | - |
| Wit Capital | New York, New York, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data 